MMN clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy

    open to eligible people ages 18 years and up

    The main purpose of this study is to compare empasiprubart and IVIg in adult patients with MMN. The study consists of a double-blinded part A (empasiprubart, IVIg) and an open-label part B (empasiprubart). The maximum study duration for participants is up to 49 months.

    at UCSF

Last updated: